Rapid7 Inc has a consensus price target of $61.19 based on the ratings of 25 analysts. The high is $140 issued by FBN Securities on September 23, 2021. The low is $40 issued by Susquehanna on May 13, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Susquehanna, and Citigroup on July 10, 2024, May 13, 2024, and May 8, 2024, respectively. With an average price target of $46 between Morgan Stanley, Susquehanna, and Citigroup, there's an implied 17.41% upside for Rapid7 Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/10/2024 | Buy Now | 17.41% | Morgan Stanley | Erin Wilson | $46 → $46 | Maintains | Equal-Weight | Get Alert |
05/13/2024 | Buy Now | 2.09% | Susquehanna | Anne Meisner | $55 → $40 | Maintains | Neutral | Get Alert |
05/10/2024 | Buy Now | — | Needham | Alex Henderson | — | Reiterates | → Hold | Get Alert |
05/08/2024 | Buy Now | 32.72% | Citigroup | Fatima Boolani | $65 → $52 | Maintains | Buy | Get Alert |
05/08/2024 | Buy Now | 45.48% | RBC Capital | Matthew Hedberg | $70 → $57 | Maintains | Outperform | Get Alert |
05/08/2024 | Buy Now | 25.06% | Barclays | Saket Kalia | $60 → $49 | Maintains | Equal-Weight | Get Alert |
05/08/2024 | Buy Now | 32.72% | Canaccord Genuity | Michael Walkley | $60 → $52 | Maintains | Hold | Get Alert |
05/08/2024 | Buy Now | 14.85% | Piper Sandler | Rob Owens | $56 → $45 | Maintains | Neutral | Get Alert |
05/08/2024 | Buy Now | 65.9% | UBS | Roger Boyd | $70 → $65 | Maintains | Buy | Get Alert |
05/08/2024 | Buy Now | 30.17% | Stifel | Gur Talpaz | $63 → $51 | Maintains | Buy | Get Alert |
05/08/2024 | Buy Now | 14.85% | Truist Securities | Joel Fishbein | $50 → $45 | Maintains | Hold | Get Alert |
05/08/2024 | Buy Now | 19.96% | Mizuho | Gregg Moskowitz | $62 → $47 | Maintains | Neutral | Get Alert |
05/08/2024 | Buy Now | 42.93% | Baird | Shrenik Kothari | $62 → $56 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | 17.41% | Scotiabank | Patrick Colville | → $46 | Initiates | → Sector Perform | Get Alert |
02/08/2024 | Buy Now | 53.14% | JP Morgan | Brian Essex | $61 → $60 | Maintains | Neutral | Get Alert |
02/08/2024 | Buy Now | 53.14% | Barclays | Saket Kalia | $58 → $60 | Maintains | Equal-Weight | Get Alert |
02/08/2024 | Buy Now | 78.66% | RBC Capital | Matthew Hedberg | → $70 | Reiterates | Outperform → Outperform | Get Alert |
01/29/2024 | Buy Now | 78.66% | UBS | Roger Boyd | $53 → $70 | Upgrade | Neutral → Buy | Get Alert |
01/10/2024 | Buy Now | — | Citigroup | Fatima Boolani | — | Upgrade | Neutral → Buy | Get Alert |
01/09/2024 | Buy Now | 65.9% | Citigroup | Fatima Boolani | $54 → $65 | Upgrade | Neutral → Buy | Get Alert |
12/11/2023 | Buy Now | 55.69% | JP Morgan | Brian Essex | $52 → $61 | Maintains | Neutral | Get Alert |
11/07/2023 | Buy Now | 40.38% | Morgan Stanley | Erin Wilson | $52 → $55 | Maintains | Equal-Weight | Get Alert |
11/03/2023 | Buy Now | 27.62% | Truist Securities | Joel Fishbein | $40 → $50 | Maintains | Hold | Get Alert |
11/03/2023 | Buy Now | 42.93% | Wolfe Research | Joshua Tilton | → $56 | Upgrade | Peer Perform → Outperform | Get Alert |
10/16/2023 | Buy Now | 40.38% | Mizuho | Gregg Moskowitz | $52 → $55 | Maintains | Neutral | Get Alert |
08/30/2023 | Buy Now | 37.83% | Citigroup | Fatima Boolani | $50 → $54 | Maintains | Neutral | Get Alert |
08/24/2023 | Buy Now | 32.72% | Canaccord Genuity | Michael Walkley | $45 → $52 | Maintains | Hold | Get Alert |
08/09/2023 | Buy Now | 32.72% | JP Morgan | Brian Essex | $50 → $52 | Maintains | Neutral | Get Alert |
08/09/2023 | Buy Now | 32.72% | Morgan Stanley | Erin Wilson | $48 → $52 | Maintains | Equal-Weight | Get Alert |
07/06/2023 | Buy Now | 27.62% | UBS | Roger Boyd | → $50 | Initiates | → Neutral | Get Alert |
06/15/2023 | Buy Now | 14.85% | Mizuho | Gregg Moskowitz | → $45 | Reiterates | Neutral → Neutral | Get Alert |
06/07/2023 | Buy Now | 53.14% | RBC Capital | Matthew Hedberg | → $60 | Reiterates | Outperform → Outperform | Get Alert |
05/23/2023 | Buy Now | 27.62% | Citigroup | Fatima Boolani | $59 → $50 | Maintains | Neutral | Get Alert |
05/10/2023 | Buy Now | 53.14% | RBC Capital | Matthew Hedberg | → $60 | Reiterates | → Outperform | Get Alert |
05/10/2023 | Buy Now | 9.75% | DA Davidson | Rudy Kessinger | $46 → $43 | Maintains | Neutral | Get Alert |
05/10/2023 | Buy Now | 32.72% | Baird | Shrenik Kothari | $56 → $52 | Maintains | Outperform | Get Alert |
05/10/2023 | Buy Now | 19.96% | Barclays | Saket Kalia | $58 → $47 | Maintains | Equal-Weight | Get Alert |
02/10/2023 | Buy Now | 14.85% | Mizuho | Gregg Moskowitz | $40 → $45 | Maintains | Neutral | Get Alert |
02/09/2023 | Buy Now | 53.14% | RBC Capital | Matthew Hedberg | → $60 | Reiterates | → Outperform | Get Alert |
02/09/2023 | Buy Now | 22.51% | Morgan Stanley | Erin Wilson | $44 → $48 | Maintains | Equal-Weight | Get Alert |
02/09/2023 | Buy Now | 32.72% | Canaccord Genuity | Michael Walkley | $55 → $52 | Downgrade | Buy → Hold | Get Alert |
02/09/2023 | Buy Now | 42.93% | Baird | Shrenik Kothari | $58 → $56 | Maintains | Outperform | Get Alert |
02/09/2023 | Buy Now | 14.85% | Mizuho | Gregg Moskowitz | $40 → $45 | Maintains | Neutral | Get Alert |
02/09/2023 | Buy Now | 48.03% | Barclays | Saket Kalia | $37 → $58 | Maintains | Equal-Weight | Get Alert |
02/09/2023 | Buy Now | 40.38% | Raymond James | Adam Tindle | $50 → $55 | Maintains | Outperform | Get Alert |
02/09/2023 | Buy Now | 32.72% | Piper Sandler | Rob Owens | $45 → $52 | Downgrade | Overweight → Neutral | Get Alert |
02/02/2023 | Buy Now | 53.14% | RBC Capital | Matthew Hedberg | $47 → $60 | Maintains | Outperform | Get Alert |
01/24/2023 | Buy Now | -3.01% | JP Morgan | Brian Essex | → $38 | Initiates | → Neutral | Get Alert |
01/13/2023 | Buy Now | -13.22% | DA Davidson | Rudy Kessinger | → $34 | Initiates | → Neutral | Get Alert |
01/05/2023 | Buy Now | 14.85% | Piper Sandler | Rob Owens | $50 → $45 | Maintains | Overweight | Get Alert |
01/04/2023 | Buy Now | -5.56% | Barclays | Saket Kalia | $40 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
12/19/2022 | Buy Now | 12.3% | Morgan Stanley | Hamza Fodderwala | $55 → $44 | Maintains | Equal-Weight | Get Alert |
12/08/2022 | Buy Now | 2.09% | Mizuho | Gregg Moskowitz | $45 → $40 | Maintains | Neutral | Get Alert |
11/16/2022 | Buy Now | — | Keybanc | Michael Turits | — | Downgrade | Overweight → Sector Weight | Get Alert |
11/03/2022 | Buy Now | 19.96% | RBC Capital | Matthew Hedberg | $57 → $47 | Maintains | Outperform | Get Alert |
11/03/2022 | Buy Now | 27.62% | Raymond James | Adam Tindle | $85 → $50 | Maintains | Outperform | Get Alert |
11/03/2022 | Buy Now | 2.09% | Barclays | Saket Kalia | $55 → $40 | Maintains | Overweight | Get Alert |
11/03/2022 | Buy Now | 14.85% | Mizuho | Gregg Moskowitz | $70 → $45 | Downgrade | Buy → Neutral | Get Alert |
11/03/2022 | Buy Now | — | Truist Securities | Joel Fishbein | — | Downgrade | Buy → Hold | Get Alert |
10/24/2022 | Buy Now | 40.38% | Morgan Stanley | Hamza Fodderwala | $80 → $55 | Maintains | Equal-Weight | Get Alert |
10/24/2022 | Buy Now | 104.19% | Truist Securities | Joel Fishbein | $95 → $80 | Maintains | Buy | Get Alert |
10/24/2022 | Buy Now | 45.48% | RBC Capital | Matthew Hedberg | $85 → $57 | Maintains | Outperform | Get Alert |
10/24/2022 | Buy Now | 45.48% | Keybanc | Michael Turits | $86 → $57 | Maintains | Overweight | Get Alert |
10/21/2022 | Buy Now | — | Needham | Alex Henderson | — | Downgrade | Buy → Hold | Get Alert |
10/19/2022 | Buy Now | 129.71% | Baird | Shrenik Kothari | → $90 | Assumes | → Outperform | Get Alert |
10/17/2022 | Buy Now | 78.66% | Mizuho | Gregg Moskowitz | $85 → $70 | Maintains | Buy | Get Alert |
10/11/2022 | Buy Now | 53.14% | Canaccord Genuity | Michael Walkley | → $60 | Initiates | → Buy | Get Alert |
09/23/2022 | Buy Now | — | BTIG | Gray Powell | — | Initiates | → Neutral | Get Alert |
08/04/2022 | Buy Now | 116.95% | Mizuho | Gregg Moskowitz | $95 → $85 | Maintains | Buy | Get Alert |
08/04/2022 | Buy Now | 104.19% | Morgan Stanley | Hamza Fodderwala | $95 → $80 | Maintains | Equal-Weight | Get Alert |
08/04/2022 | Buy Now | 231.8% | Raymond James | Adam Tindle | $125 → $130 | Maintains | Outperform | Get Alert |
08/04/2022 | Buy Now | 129.71% | Needham | Alex Henderson | $155 → $90 | Maintains | Buy | Get Alert |
08/01/2022 | Buy Now | 116.95% | RBC Capital | Matthew Hedberg | $140 → $85 | Maintains | Outperform | Get Alert |
07/22/2022 | Buy Now | 104.19% | Citigroup | Fatima Boolani | $100 → $80 | Maintains | Neutral | Get Alert |
07/22/2022 | Buy Now | 134.81% | Keybanc | Michael Turits | $129 → $92 | Maintains | Overweight | Get Alert |
07/19/2022 | Buy Now | 142.47% | Mizuho | Gregg Moskowitz | $110 → $95 | Maintains | Buy | Get Alert |
07/12/2022 | Buy Now | 134.81% | Barclays | Saket Kalia | $110 → $92 | Maintains | Overweight | Get Alert |
05/05/2022 | Buy Now | 142.47% | Morgan Stanley | Hamza Fodderwala | $103 → $95 | Maintains | Equal-Weight | Get Alert |
05/05/2022 | Buy Now | 180.76% | Mizuho | Gregg Moskowitz | $135 → $110 | Maintains | Buy | Get Alert |
05/05/2022 | Buy Now | 219.04% | Raymond James | Adam Tindle | $145 → $125 | Maintains | Outperform | Get Alert |
05/05/2022 | Buy Now | 206.28% | Piper Sandler | Rob Owens | $140 → $120 | Maintains | Overweight | Get Alert |
04/12/2022 | Buy Now | — | Goldman Sachs | Brian Essex | — | Downgrade | Buy → Neutral | Get Alert |
04/11/2022 | Buy Now | 211.38% | Wolfe Research | Joshua Tilton | → $122 | Initiates | → Outperform | Get Alert |
02/10/2022 | Buy Now | 211.38% | Barclays | Saket Kalia | $120 → $122 | Maintains | Overweight | Get Alert |
02/10/2022 | Buy Now | 229.25% | Keybanc | Michael Turits | $126 → $129 | Maintains | Overweight | Get Alert |
02/07/2022 | Buy Now | 231.8% | RBC Capital | Matthew Hedberg | $157 → $130 | Maintains | Outperform | Get Alert |
02/02/2022 | Buy Now | 221.59% | Keybanc | Michael Turits | $162 → $126 | Maintains | Overweight | Get Alert |
01/18/2022 | Buy Now | 162.89% | Morgan Stanley | Hamza Fodderwala | $106 → $103 | Maintains | Equal-Weight | Get Alert |
11/04/2021 | Buy Now | 170.55% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
11/04/2021 | Buy Now | 300.71% | RBC Capital | Matthew Hedberg | — | Maintains | Outperform | Get Alert |
11/04/2021 | Buy Now | 295.61% | Mizuho | Gregg Moskowitz | — | Maintains | Buy | Get Alert |
11/04/2021 | Buy Now | 270.09% | Raymond James | Adam Tindle | — | Maintains | Outperform | Get Alert |
11/04/2021 | Buy Now | 295.61% | Needham | Alex Henderson | — | Maintains | Buy | Get Alert |
11/04/2021 | Buy Now | 313.48% | Keybanc | Michael Turits | — | Maintains | Overweight | Get Alert |
11/01/2021 | Buy Now | 282.85% | RBC Capital | Matthew Hedberg | — | Maintains | Outperform | Get Alert |
10/18/2021 | Buy Now | 252.22% | Mizuho | Gregg Moskowitz | — | Maintains | Buy | Get Alert |
09/23/2021 | Buy Now | 257.33% | FBN Securities | — | — | Initiates | → Outperform | Get Alert |
08/06/2021 | Buy Now | 231.8% | Goldman Sachs | — | — | Maintains | Buy | Get Alert |
08/05/2021 | Buy Now | 147.58% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
08/05/2021 | Buy Now | 231.8% | Raymond James | Adam Tindle | — | Maintains | Outperform | Get Alert |
The latest price target for Rapid7 (NASDAQ:RPD) was reported by Morgan Stanley on July 10, 2024. The analyst firm set a price target for $46.00 expecting RPD to rise to within 12 months (a possible 17.41% upside). 29 analyst firms have reported ratings in the last year.
The latest analyst rating for Rapid7 (NASDAQ:RPD) was provided by Morgan Stanley, and Rapid7 maintained their equal-weight rating.
The last upgrade for Rapid7 Inc happened on January 29, 2024 when UBS raised their price target to $70. UBS previously had a neutral for Rapid7 Inc.
The last downgrade for Rapid7 Inc happened on February 9, 2023 when Canaccord Genuity changed their price target from $55 to $52 for Rapid7 Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rapid7, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rapid7 was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
While ratings are subjective and will change, the latest Rapid7 (RPD) rating was a maintained with a price target of $46.00 to $46.00. The current price Rapid7 (RPD) is trading at is $39.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.